Rubicon Advisors’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$392K Buy
+2,035
New +$219K 0.27% 67

Other funds holding MRNA

Rubicon Advisors's MRNA Position: Q3 2026 in Review

Rubicon Advisors opened a new position in Moderna (MRNA) in Q3 2026: 2,035 shares worth $392K. The stake represents 0.27% of the portfolio and ranks #67 among its holdings.

1,048 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Rubicon Advisors held 2,035 shares of Moderna worth $392K as of Q3 2026.
  • Moderna was a new Rubicon Advisors position in Q3 2026.
  • Moderna made up 0.27% of Rubicon Advisors's portfolio in Q3 2026, its #67 holding.
  • 1,048 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Rubicon Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.